MYX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mayne Pharma Group Ltd

Watchlist Manager

Watchlist

Price: 2.88 AUD -1.37% Market Closed

Market Cap: AU$234m

	Mayne Pharma Group Ltd ASX:MYX	AU
S	Sarepta Therapeutics Inc XBER:AB3A	US
S	Sandfire Resources Ltd XMUN:S2Z	AU
	Vale Indonesia Tbk PT OTC:PTNDF	ID
T	TomTom NV F:OEMA	NL
L	LEG Immobilien SE F:LEG	DE

Profitability Summary

Mayne Pharma Group Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

63%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

48% > 63%

Negative Operating Margin

-7%

Negative 3Y Average Operating Margin

-35%

Operating Margin is Increasing

-87% > -7%

Negative Net Margin

-20%

Negative 3Y Average Net Margin

-24%

Declining Net Margin

62% > -20%

Negative Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-28%

Free Cash Flow Margin is Increasing

-138% > 0%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-11%

ROIC is Increasing

-18% > -4%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.